196 related articles for article (PubMed ID: 26516128)
1. The Role of Wnt Signaling in Squamous Cell Carcinoma.
Shiah SG; Shieh YS; Chang JY
J Dent Res; 2016 Feb; 95(2):129-34. PubMed ID: 26516128
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
[TBL] [Abstract][Full Text] [Related]
3. Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Shiah SG; Hsiao JR; Chang WM; Chen YW; Jin YT; Wong TY; Huang JS; Tsai ST; Hsu YM; Chou ST; Yen YC; Jiang SS; Shieh YS; Chang IS; Hsiao M; Chang JY
Cancer Res; 2014 Dec; 74(24):7560-72. PubMed ID: 25351956
[TBL] [Abstract][Full Text] [Related]
4. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
5. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.
Ma Y; Hu X; Shang C; Zhong M; Guo Y
Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055
[TBL] [Abstract][Full Text] [Related]
6. Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma.
Palmieri A; Carinci F; Martinelli M; Pezzetti F; Girardi A; Cura F; Rubini C; Scapoli L
Eur J Oral Sci; 2014 Jun; 122(3):198-201. PubMed ID: 24612133
[TBL] [Abstract][Full Text] [Related]
7. The anti-apoptotic PON2 protein is Wnt/β-catenin-regulated and correlates with radiotherapy resistance in OSCC patients.
Krüger M; Amort J; Wilgenbus P; Helmstädter JP; Grechowa I; Ebert J; Tenzer S; Moergel M; Witte I; Horke S
Oncotarget; 2016 Aug; 7(32):51082-51095. PubMed ID: 27322774
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H
Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949
[TBL] [Abstract][Full Text] [Related]
9. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
Vidya Priyadarsini R; Senthil Murugan R; Nagini S
Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
[TBL] [Abstract][Full Text] [Related]
10. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.
Jamal B; Sengupta PK; Gao ZN; Nita-Lazar M; Amin B; Jalisi S; Bouchie MP; Kukuruzinska MA
Oral Oncol; 2012 Jun; 48(6):523-9. PubMed ID: 22341307
[TBL] [Abstract][Full Text] [Related]
11. KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.
Cui Z; Cui Y; Yang S; Luo G; Wang Y; Lou Y; Sun X
Cell Biol Int; 2017 Apr; 41(4):392-404. PubMed ID: 28150891
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
[TBL] [Abstract][Full Text] [Related]
13. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma.
Marimuthu M; Andiappan M; Wahab A; Muthusekhar MR; Balakrishnan A; Shanmugam S
Indian J Dent Res; 2018; 29(3):291-297. PubMed ID: 29900911
[TBL] [Abstract][Full Text] [Related]
14. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
[TBL] [Abstract][Full Text] [Related]
15. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
Pérez-Sayáns M; Pilar GD; Barros-Angueira F; Suárez-Peñaranda JM; Fernández AC; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
[TBL] [Abstract][Full Text] [Related]
16. Global analysis of DNA methylation changes during progression of oral cancer.
Towle R; Truong D; Hogg K; Robinson WP; Poh CF; Garnis C
Oral Oncol; 2013 Nov; 49(11):1033-42. PubMed ID: 24035722
[TBL] [Abstract][Full Text] [Related]
17. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.
Tsuchiya R; Yamamoto G; Nagoshi Y; Aida T; Irie T; Tachikawa T
Oral Oncol; 2004 Oct; 40(9):932-40. PubMed ID: 15380172
[TBL] [Abstract][Full Text] [Related]
18. The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma.
Pérez-Sayáns M; Suárez-Peñaranda JM; Herranz-Carnero M; Gayoso-Diz P; Barros-Angueira F; Gándara-Rey JM; García-García A
Oral Oncol; 2012 Jan; 48(1):56-60. PubMed ID: 21937258
[TBL] [Abstract][Full Text] [Related]
19. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
